Top Science Scandals of 2012

This year’s roundup of bad behavior in the life sciences and new initiatives to prevent misconduct

Written byEdyta Zielinska
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Eppendorf tubesFlickr, opiadoA widely discussed research study published this year showed that more than sloppy mistakes or accidental omissions, retracted papers are most likely to be withdrawn from publication because of scientific misconduct or knowlingly publishing false data. In fact, more than 65 percent of the 2,000 or so papers studied were retracted because of poor ethical judgment. According to that report, high impact journals have been hardest hit by the increasing rate of retractions over the past decade.

In light of these findings, researchers and other observers have proposed several initiatives to help the scientific community with its apparent honesty issues. One suggestion was the creation a Retraction Index. Unlike the Impact Factor, which is based on a journal’s citation rate, the Retraction Index would indicate the number of retractions a journal has for every 1,000 papers published. Following suit, Adam Marcus and Ivan Oransky at Retraction Watch blog suggested creating a Transparency Index, which could include a score for how well a journal controls its manuscript review process, including how it conducts peer review, whether supporting data are also reviewed, whether the journal uses plagiarism detecting software, and a number of other measures. Finally, the lab-services start-up Science Exchange and the open ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies